Suchergebnisse - "Byers, Lauren Averett"

PubPharm (71)

1

Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer

enthalten in: EBioMedicine | 2024

von Park, S. | Hong, T. | Hwang, S. | +17

2

YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities

enthalten in: bioRxiv.org | 2023

von Stewart, C. | Diao, L. | Xi, Y. | +25

3

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer : the phase 2 platform NEOSTAR trial

enthalten in: Nature medicine | 2023

von Cascone, T. | Leung, C. | Weissferdt, A. | +54

4

BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

enthalten in: NPJ precision oncology | 2023

von Nelson, B. | Roszik, J. | Janku, F. | +13

5

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

enthalten in: Journal of translational medicine | 2022

von Della Corte, C. | Ciaramella, V. | Ramkumar, K. | +19

6

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

enthalten in: Journal of translational medicine | 2022

von Della Corte, C. | Ciaramella, V. | Ramkumar, K. | +19

7

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

enthalten in: Journal of translational medicine | 2022

von Della Corte, C. | Ciaramella, V. | Ramkumar, K. | +19

8

A wake-up call for cancer DNA damage : the role of Schlafen 11 (SLFN11) across multiple cancers

enthalten in: British journal of cancer | 2021

von Zhang, B. | Ramkumar, K. | Cardnell, R. | +6

9

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2021

von Byers, L. | Navarro, A. | Schaefer, E. | +12

10

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer : A Randomized, Multicenter Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Ramalingam, S. | Novello, S. | Guclu, S. | +18

1
2
3
4
5
6
7
8
Nächster »
[8]